Paper41585259
Comparison of the efficacy of thalidomide combined with low-dose rituximab and low-dose rituximab alone in the treatment of steroid-resistant/refractory adult patients with primary immune thrombocytopenia: an open-label trial.
Yang S and 9 others. Front Med (Lausanne), 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Comparison of the efficacy of thalidomide combined with low-dose rituximab and low-dose rituximab alone in the treatment of steroid-resistant/refractory adult patients with primary immune thrombocytopenia: an open-label trial. Papers, record 41585259. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41585259
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Comparison of the efficacy of thalidomide combined with low-dose rituximab and low-dose rituximab alone in the treatment of steroid-resistant/refractory adult patients with primary immune thrombocytopenia: an open-label trial.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34660807 | The Efficacy and Safety of Different Dosages of Rituximab for Adults with Immune Thrombocytopenia: A Systematic Review and Meta-Analysis. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/34660807 | PubMed |
| 2 | 34665865 | All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP. | Blood | 2022 | https://conductscience.org/library/papers/34665865 | PubMed |
| 3 | 22117897 | Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia. | Curr Med Res Opin | 2012 | https://conductscience.org/library/papers/22117897 | PubMed |
| 4 | 37081607 | Assessment of circulating blood lymphocytes in adult patients on rituximab to treat immune thrombocytopenia: Circulating number of NK cells is associated with the response at 6 months. | Br J Haematol | 2023 | https://conductscience.org/library/papers/37081607 | PubMed |
| 5 | 19399582 | Phase II and pharmacokinetic study of thalidomide in Japanese patients with relapsed/refractory multiple myeloma. | Int J Hematol | 2009 | https://conductscience.org/library/papers/19399582 | PubMed |
| 6 | 31866622 | T-cell large granular lymphocytic (LGL) leukemia consists of CD4+/CD8dim and CD4-/CD8+ LGL populations in association with immune thrombocytopenia, autoimmune neutropenia, and monoclonal B-cell lymphocytosis. | J Clin Exp Hematop | 2019 | https://conductscience.org/library/papers/31866622 | PubMed |
| 7 | 32071327 | Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4. | Sci Rep | 2020 | https://conductscience.org/library/papers/32071327 | PubMed |
| 8 | 33206273 | Thalidomide Inhibits Angiogenesis via Downregulation of VEGF and Angiopoietin-2 in Crohn's Disease. | Inflammation | 2021 | https://conductscience.org/library/papers/33206273 | PubMed |
| 9 | 24460857 | Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP). | Clin Exp Immunol | 2014 | https://conductscience.org/library/papers/24460857 | PubMed |
| 10 | 23926306 | Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia. | Blood | 2013 | https://conductscience.org/library/papers/23926306 | PubMed |
| 11 | 31770441 | Updated international consensus report on the investigation and management of primary immune thrombocytopenia. | Blood Adv | 2019 | https://conductscience.org/library/papers/31770441 | PubMed |
| 12 | 30648105 | Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/30648105 | PubMed |
| 13 | 20546023 | Low-dose rituximab in adult patients with primary immune thrombocytopenia. | Eur J Haematol | 2010 | https://conductscience.org/library/papers/20546023 | PubMed |
| 14 | 31884963 | CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells. | J Neuroinflammation | 2019 | https://conductscience.org/library/papers/31884963 | PubMed |
| 15 | 32573072 | Antimetastatic effects of thalidomide by inducing the functional maturation of peripheral natural killer cells. | Cancer Sci | 2020 | https://conductscience.org/library/papers/32573072 | PubMed |
| 16 | 40108021 | Addition of thalidomide for prevention of chemotherapy-induced nausea and vomiting in the second cycle after the failure of four-drug regimen in the first cycle. | Med Oncol | 2025 | https://conductscience.org/library/papers/40108021 | PubMed |
| 17 | 15172781 | Thalidomide. | Lancet | 2004 | https://conductscience.org/library/papers/15172781 | PubMed |
| 18 | 36966238 | Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis. | Inflammopharmacology | 2023 | https://conductscience.org/library/papers/36966238 | PubMed |
| 19 | 31794604 | American Society of Hematology 2019 guidelines for immune thrombocytopenia. | Blood Adv | 2019 | https://conductscience.org/library/papers/31794604 | PubMed |
| 20 | 21039469 | Natural killer cells in human autoimmune diseases. | Immunology | 2010 | https://conductscience.org/library/papers/21039469 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FCGR3A | 2214 | PubTator's text mining | https://conductscience.org/library/genes/2214 | NCBI Gene |
| NCAM1 | 4684 | PubTator's text mining | https://conductscience.org/library/genes/4684 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41585259
GET https://conductscience.org/api/papers/v1/41585259/references?page=2